DR. HAROLD H HARRISON, M.D., PH.D.
Osteopathic Medicine at Beryl Ave, Phoenix, AZ
License number
Arizona 21513
Category
Medical Practice
Type
Clinical Cytogenetic
License number
Arizona 21513
Category
Medical Practice
Type
Clinical Genetics (M.D.)
License number
Arizona 21513
Category
Medical Practice
Type
Clinical Biochemical Genetics
License number
Arizona 21513
Category
Medical Practice
Type
Molecular Genetic Pathology
License number
Arizona 21513
Category
Medical Practice
Type
Hematology
License number
Arizona 21513
Category
Medical Practice
Type
Immunopathology
License number
Arizona 21513
Category
Medical Practice
Type
Molecular Genetic Pathology
License number
Arizona 21513
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
License number
Arizona 21513
Category
Osteopathic Medicine
Type
General Practice
Address
Address
2
2505 W Beryl Ave SUITE 100, Phoenix, AZ 85021
3031 N. Civic Center Plz SUITE 228, Scottsdale, AZ 85251
3031 N. Civic Center Plz SUITE 228, Scottsdale, AZ 85251
Phone
(602) 997-9161
(602) 997-1406 (Fax)
(480) 423-1701
(480) 423-1704 (Fax)
(602) 997-1406 (Fax)
(480) 423-1701
(480) 423-1704 (Fax)
Organization information
See more information about HAROLD H HARRISON at bizstanding.comHAROLD H. HARRISON, M.D., PC
2432 W Peoria Ave #1282, Phoenix, AZ 85029
Registration:
Aug 6, 2001
State ID:
-0993533-3
Expiration:
PERPETUAL
Directors:
Harold H Harrison Md (President), 138 Dogwood Ln, Lewisburg, PA 17837 (Physical),Harold H Harrison (Director), Director 138 Dogwood Ln, Lewisburg, PA 17837 (Physical)
Business type:
SCIENCE/RESEARCH
Professional information
Method For Detecting Procoagulant Genetic And Metabolic Conditions Associated With, And Potentially Predispositional For, Activation Of The Coagulation Response
US Patent:
7264936, Sep 4, 2007
Filed:
Aug 10, 2004
Appl. No.:
10/915018
Inventors:
David E. Berg - Phoenix AZ, US
Lois Hill Berg - Phoenix AZ, US
Harold H. Harrison - Scottsdale AZ, US
Lois Hill Berg - Phoenix AZ, US
Harold H. Harrison - Scottsdale AZ, US
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
Methods for diagnosing and identifying genetic and metabolic factors associated with a physiologic procoagulant predisposition for and concurrent activation of the coagulation response in patients suffering from conditions such as chronic fatigue syndrome, fibromyalgia, Gulf War illness and cardiovascular disease are disclosed. Diagnostic assays utilized in the methods include measurement of blood levels of Protein C, Protein S, antithrombin, activated protein C resistance, prothrombin, plasminogen activator inhibitor-1, lipoprotein (a) and homocysteine. Treatment regimens include anticoagulant therapies comprising administering warfarin or heparin as needed.
Method For Detecting Procoagulant Genetic And Metabolic Conditions Associated With, And Potentially Predispositional For, Activation Of The Coagulation Response
US Patent:
2002003, Mar 28, 2002
Filed:
Sep 28, 2001
Appl. No.:
09/966311
Inventors:
David Berg - Phoenix AZ, US
Lois Berg - Phoenix AZ, US
Harold Harrison - Scottsdale AZ, US
Lois Berg - Phoenix AZ, US
Harold Harrison - Scottsdale AZ, US
International Classification:
C12Q001/68, G01N033/567, C12Q001/56
US Classification:
435/006000, 435/007210, 435/013000
Abstract:
Methods for diagnosing and identifying genetic and metabolic factors associated with a physiologic procoagulant predisposition for and concurrent activation of the coagulation response in patients suffering from conditions such as chronic fatigue syndrome, fibromyalgia, Gulf War illness and cardiovascular disease are disclosed. Diagnostic assays utilized in the methods include measurement of blood levels of Protein C, Protein S, antithrombin, activated protein C resistance, prothrombin plasminogen activator inhibitor-1, lipoprotein (a) and homocysteine. Treatment regimens include anticoagulant therapies comprising administering warfarin or heparin as needed.